Search Results - "Eriksen, Ann C"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Spatial expression analyses of the putative oncogene ciRS-7 in cancer reshape the microRNA sponge theory by Kristensen, Lasse S., Ebbesen, Karoline K., Sokol, Martin, Jakobsen, Theresa, Korsgaard, Ulrik, Eriksen, Ann C., Hansen, Thomas B., Kjems, Jørgen, Hager, Henrik

    Published in Nature communications (11-09-2020)
    “…Circular RNAs (circRNAs) have recently gained substantial attention in the cancer research field where most, including the putative oncogene ciRS-7 (CDR1as),…”
    Get full text
    Journal Article
  2. 2

    Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort by Eriksen, Ann C, Sørensen, Flemming B, Lindebjerg, Jan, Hager, Henrik, dePont Christensen, René, Kjær-Frifeldt, Sanne, Hansen, Torben F

    Published in BMC cancer (12-02-2019)
    “…Patients suffering from high risk stage II colon cancer (CC) may benefit from adjuvant onco-therapy, but additional prognostic markers are needed for better…”
    Get full text
    Journal Article
  3. 3

    The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study by Eriksen, Ann C., Sørensen, Flemming B., Lindebjerg, Jan, Hager, Henrik, dePont Christensen, René, Kjær-Frifeldt, Sanne, Hansen, Torben F.

    Published in Translational oncology (01-08-2018)
    “…BACKGROUND: Additional prognostic markers are needed for better treatment stratification of stage II colon cancer (CC). We investigated the prognostic value of…”
    Get full text
    Journal Article
  4. 4

    Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer by Eriksen, Ann C, Andersen, Johnnie B, Kristensson, Martin, dePont Christensen, René, Hansen, Torben F, Kjær-Frifeldt, Sanne, Sørensen, Flemming B

    Published in Diagnostic pathology (29-08-2017)
    “…Precise prognostic and predictive variables allowing improved post-operative treatment stratification are missing in patients treated for stage II colon cancer…”
    Get full text
    Journal Article
  5. 5

    Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer? by Eriksen, Ann C, Andersen, Johnnie B, Lindebjerg, Jan, dePont Christensen, René, Hansen, Torben F, Kjær-Frifeldt, Sanne, Sørensen, Flemming B

    Published in Diagnostic pathology (20-03-2018)
    “…Tumour budding (TB) and Tumour Stroma Ratio (TSR) may be rewarding in the treatment stratification of patients with stage II colon cancer. However, lack of…”
    Get full text
    Journal Article
  6. 6

    The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study1 by Eriksen, Ann C., Sørensen, Flemming B., Lindebjerg, Jan, Hager, Henrik, dePont Christensen, René, Kjær-Frifeldt, Sanne, Hansen, Torben F.

    Published in Translational oncology (22-06-2018)
    “…BACKGROUND: Additional prognostic markers are needed for better treatment stratification of stage II colon cancer (CC). We investigated the prognostic value of…”
    Get full text
    Journal Article